← Back to Search

Behavioral Intervention

Digital Intervention for Problem Drinking

N/A
Waitlist Available
Led By Dongju Seo, PhD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Either high or low COVID-19 related stress
Heavy or binge drinkers
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, after intervention (up to 30 days)
Awards & highlights

Study Summary

This trial will study the effects of stress related to COVID-19 on social drinkers who are at risk for alcohol misuse. The trial will use digital interventions to help participants manage their stress.

Who is the study for?
This trial is for people who drink heavily or binge and are experiencing high or low stress related to COVID-19. It's not suitable for those with serious medical conditions, psychiatric disorders (other than mood and anxiety), or a history of substance abuse beyond mild alcohol, tobacco, or marijuana use.Check my eligibility
What is being tested?
The study is testing digital interventions over a 4-week period to see if they can reduce hazardous drinking in individuals stressed by the pandemic. The focus is on how stress influences the risk of alcohol misuse and response to treatment.See study design
What are the potential side effects?
Since this trial involves digital interventions rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort when discussing their drinking habits and stress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have either very high or very low stress related to COVID-19.
Select...
You drink too much alcohol regularly or have episodes of excessive drinking.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, after intervention (up to 30 days)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, after intervention (up to 30 days) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in alcohol use (frequency)
Change in alcohol use (quantity)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Risky drinkersExperimental Treatment1 Intervention
All participants will receive the same 4 week intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
4-week intervention
2021
N/A
~40

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
791 Previous Clinical Trials
1,356,951 Total Patients Enrolled
4 Trials studying Problem Drinking
2,009 Patients Enrolled for Problem Drinking
Yale UniversityLead Sponsor
1,836 Previous Clinical Trials
2,727,240 Total Patients Enrolled
2 Trials studying Problem Drinking
157 Patients Enrolled for Problem Drinking
Dongju Seo, PhDPrincipal InvestigatorYale University
1 Previous Clinical Trials
148 Total Patients Enrolled

Media Library

4-week intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04890652 — N/A
Problem Drinking Research Study Groups: Risky drinkers
Problem Drinking Clinical Trial 2023: 4-week intervention Highlights & Side Effects. Trial Name: NCT04890652 — N/A
4-week intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04890652 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for me to become a participant in this clinical trial?

"To meet the criteria for this clinical trial, prospective participants must have a history of alcohol-impaired driving and fall in the age range between 18 and 55. This medical study is looking to recruit 40 individuals in total."

Answered by AI

Does this clinical investigation accept participants of legal age?

"Patients eligible to join this trial must be between 18 and 55 years old. There are 21 studies for those younger than 18, as well as 108 trials available for seniors aged 65 or above."

Answered by AI

What is the participant cap of this research endeavor?

"Affirmative. Clinicaltrials.gov suggests that recruitment is currently active for this study, which was initially posted on October 13th 2021 and updated most recently on November 11th 2022. The trial aims to enrol 40 individuals from 1 different medical centre."

Answered by AI

Is this research protocol presently enrolling participants?

"Affirmative. According to clinicaltrials.gov, recruitment is ongoing for this medical trial, which was first published on October 13th 2021 and most recently amended on November 11th 2022."

Answered by AI
~10 spots leftby Mar 2025